A partnership between the University of Cincinnati and Cincinnati Children’s Hospital has landed more than $37 million in ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...

These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...

"Our study shows that reaching patients directly with digital tools can help overcome barriers to lung cancer screening and ...

During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...

“By accelerating research into sex and biological differences, we can not only improve outcomes but also reduce health-care costs and boost the economy,” Lee said, adding that investing $350 million ...

To continue Ohio State’s suicide prevention research, the university’s project ARTEMIS received $19.5 million from the National Institutes of Health (NIH) to study suicide risk factors and prediction.

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...